| scholarly article | Q13442814 |
| P50 | author | Grace John-Stewart | Q47146705 |
| Dorothy Mbori-Ngacha | Q56636304 | ||
| Julie Overbaugh | Q60607958 | ||
| Barbra A Richardson | Q60608309 | ||
| Ruth Nduati | Q84100034 | ||
| P2093 | author name string | Ludo Lavreys | |
| Joan K Kreiss | |||
| Sandra Emery | |||
| Dana D Panteleeff | |||
| P2860 | cites work | Gender differences in HIV-1 diversity at time of infection | Q24706473 |
| Effect of breastfeeding and formula feeding on transmission of HIV-1: a randomized clinical trial | Q28137803 | ||
| Rapid method for screening dried blood samples on filter paper for human immunodeficiency virus type 1 DNA | Q33958648 | ||
| Evaluation of performance of the Gen-Probe human immunodeficiency virus type 1 viral load assay using primary subtype A, C, and D isolates from Kenya | Q33968241 | ||
| Does patient sex affect human immunodeficiency virus levels? | Q34736412 | ||
| Dynamics of viral replication in infants with vertically acquired human immunodeficiency virus type 1 infection. | Q37350178 | ||
| Primary HIV infection of infants: the effects of somatic growth on lymphocyte and virus dynamics | Q41680450 | ||
| Viral load and disease progression in infants infected with human immunodeficiency virus type 1. Women and Infants Transmission Study Group | Q44142380 | ||
| Level and pattern of HIV-1-RNA viral load over age: differences between girls and boys? | Q44951422 | ||
| Maternal and infant factors predicting disease progression in human immunodeficiency virus type 1-infected infants. Women and Infants Transmission Study Group | Q45745351 | ||
| Patterns of viral dynamics during primary human immunodeficiency virus type 1 infection. The Sydney Primary HIV Infection Study Group. | Q45752836 | ||
| Early prognostic indicators in primary perinatal human immunodeficiency virus type 1 infection: importance of viral RNA and the timing of transmission on long-term outcome | Q45754371 | ||
| Association of human immunodeficiency virus (HIV) load early in life with disease progression among HIV-infected infants. New York City Perinatal HIV Transmission Collaborative Study Group | Q45755099 | ||
| Delayed generation of antibodies mediating human immunodeficiency virus type 1-specific antibody-dependent cellular cytotoxicity in vertically infected infants. WITS Study Group. Women and Infants Transmission Study | Q45760643 | ||
| Human immunodeficiency virus-1 infection in neonates: correlation of plasma and cellular viremia and clinical outcome. French Pediatric Cohort Study Group | Q45761434 | ||
| Age- and time-related changes in extracellular viral load in children vertically infected by human immunodeficiency virus | Q45765734 | ||
| Time course of detection of viral and serologic markers preceding human immunodeficiency virus type 1 seroconversion: implications for screening of blood and tissue donors | Q45784529 | ||
| Viral levels in newborn African infants undergoing primary HIV-1 infection | Q57207576 | ||
| Association of HIV-1 load and CD4 lymphocyte count with mortality among untreated African children over one year of age | Q57207579 | ||
| Preparation for AIDS vaccine evaluation in Mombasa, Kenya: establishment of seronegative cohorts of commercial sex workers and trucking company employees | Q72567509 | ||
| HIV-1-specific cytotoxic T lymphocyte responses in the first year of life | Q72896097 | ||
| Initial plasma HIV-1 RNA levels and progression to AIDS in women and men | Q73583102 | ||
| Predictive value of quantitative plasma HIV RNA and CD4+ lymphocyte count in HIV-infected infants and children | Q74329600 | ||
| Biological and virologic characteristics of primary HIV infection | Q74429764 | ||
| P433 | issue | 12 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | Kenya | Q114 |
| viral load | Q2528140 | ||
| P304 | page(s) | 7120-7123 | |
| P577 | publication date | 2003-06-01 | |
| P1433 | published in | Journal of Virology | Q1251128 |
| P1476 | title | Comparison of human immunodeficiency virus type 1 viral loads in Kenyan women, men, and infants during primary and early infection | |
| P478 | volume | 77 |
| Q35036289 | A phase I randomized clinical trial of candidate human immunodeficiency virus type 1 vaccine MVA.HIVA administered to Gambian infants |
| Q36128518 | AIDS among older children and adolescents in Southern Africa: projecting the time course and magnitude of the epidemic |
| Q47094547 | Alterations in B Cell Compartment Correlate with Poor Neutralization Response and Disease Progression in HIV-1 Infected Children |
| Q34437641 | Associations of host genetic variants on CD4⁺ lymphocyte count and plasma HIV-1 RNA in antiretroviral naïve children |
| Q56974226 | Broadly neutralizing antibodies: What is needed to move from a rare event in HIV-1 infection to vaccine efficacy? |
| Q45333913 | CD4-Binding Site Directed Cross-Neutralizing scFv Monoclonals from HIV-1 Subtype C Infected Indian Children |
| Q40722440 | Changes in soluble factor-mediated CD8+ cell-derived antiviral activity in cynomolgus macaques infected with simian immunodeficiency virus SIVmac251: relationship to biological markers of progression |
| Q58028262 | Chronic knee stiffness and swelling in a Zimbabwean adolescent |
| Q36251762 | Comparison of developmental milestone attainment in early treated HIV-infected infants versus HIV-unexposed infants: a prospective cohort study |
| Q35907285 | Cross-subtype detection of HIV-1 using reverse transcription and recombinase polymerase amplification |
| Q40548877 | Differences in virologic and immunologic response to antiretroviral therapy among HIV-1-infected infants and children |
| Q33764917 | Early development of broadly neutralizing antibodies in HIV-1-infected infants |
| Q36581538 | Efficiency of human immunodeficiency virus transmission through injections and other medical procedures: evidence, estimates, and unfinished business |
| Q36302010 | FCGR2A and FCGR3A Genotypes in Human Immunodeficiency Virus Mother-to-Child Transmission |
| Q42256450 | Guidance and practice on frequency of HIV and sexually transmitted infection testing in men who have sex with men - what is the European situation? |
| Q41919022 | HIV drug resistance in African infants and young children newly diagnosed with HIV: a multicounty analysis |
| Q57096915 | HIV infection |
| Q34430211 | HIV type 1 (HIV-1) proviral reservoirs decay continuously under sustained virologic control in HIV-1-infected children who received early treatment |
| Q37363152 | How effectively can HIV phylogenies be used to measure heritability? |
| Q36315692 | Human immunodeficiency virus-specific CD8+ T-cell activity is detectable from birth in the majority of in utero-infected infants |
| Q37006608 | Immune approaches for the prevention of breast milk transmission of HIV-1. |
| Q34389901 | Immune-based approaches to the prevention of mother-to-child transmission of HIV-1: active and passive immunization |
| Q37579676 | Immuno-haematologic and virologic responses and predictors of virologic failure in HIV-1 infected adults on first-line antiretroviral therapy in Cameroon |
| Q42214247 | In-utero infection with HIV-1 associated with suppressed lymphoproliferative responses at birth. |
| Q47812016 | Infants with late breast milk acquisition of HIV-1 generate interferon-gamma responses more rapidly than infants with early peripartum acquisition |
| Q92881041 | Intrinsic Replication Competences of HIV Strains After Zidovudine/Lamivudine/Nevirapine Treatment in the Philippines |
| Q34439549 | Laser cutting eliminates nucleic acid cross-contamination in dried-blood-spot processing |
| Q33843438 | Longitudinal assessment of human immunodeficiency virus type 1 (HIV-1)-specific gamma interferon responses during the first year of life in HIV-1-infected infants |
| Q36060517 | Low-frequency nevirapine resistance at multiple sites may predict treatment failure in infants on nevirapine-based treatment |
| Q45200255 | Mother-to-child transmission of HIV: a global perspective |
| Q35942341 | Nevirapine Resistance in Previously Nevirapine-Unexposed HIV-1-Infected Kenyan Infants Initiating Early Antiretroviral Therapy |
| Q35352866 | Passively acquired antibody-dependent cellular cytotoxicity (ADCC) activity in HIV-infected infants is associated with reduced mortality |
| Q35554825 | PedVacc 002: a phase I/II randomized clinical trial of MVA.HIVA vaccine administered to infants born to human immunodeficiency virus type 1-positive mothers in Nairobi |
| Q37379992 | Pediatric HIV-1 in Kenya: pattern and correlates of viral load and association with mortality |
| Q33927135 | Phenotypic characterization of HIV-specific CD8+ T cells during early and chronic infant HIV-1 infection |
| Q35140678 | Plasma and cervical viral loads among Ugandan and Zimbabwean women during acute and early HIV-1 infection |
| Q36995136 | Precise determination of time to reach viral load set point after acute HIV-1 infection. |
| Q30828875 | Prospective Study of Acute HIV-1 Infection in Adults in East Africa and Thailand |
| Q30354950 | Rapid virus dissemination in infant macaques after oral simian immunodeficiency virus exposure in the presence of local innate immune responses |
| Q94561594 | Redirection of Cord Blood T Cells and Natural Killer Cells for Elimination of Autologous HIV-1-Infected Target Cells Using Bispecific DART® Molecules |
| Q33987771 | Risk factors associated with increased mortality among HIV infected children initiating antiretroviral therapy (ART) in South Africa |
| Q35178669 | Sex differences in HIV RNA level and CD4 cell percentage during childhood |
| Q59357139 | Simian Immunodeficiency Virus Persistence in Cellular and Anatomic Reservoirs in Antiretroviral Therapy-Suppressed Infant Rhesus Macaques |
| Q92049906 | Simian-Human Immunodeficiency Virus SHIV.CH505-Infected Infant and Adult Rhesus Macaques Exhibit Similar Env-Specific Antibody Kinetics, despite Distinct T-Follicular Helper and Germinal Center B Cell Landscapes |
| Q36496904 | The impact of HIV-1 infection and exposure on natural killer (NK) cell phenotype in Kenyan infants during the first year of life |
| Q30374404 | The rhesus macaque pediatric SIV infection model - a valuable tool in understanding infant HIV-1 pathogenesis and for designing pediatric HIV-1 prevention strategies |
| Q35542406 | The role of co-infections in mother-to-child transmission of HIV. |
| Q35847795 | Timely triggering of homeostatic mechanisms involved in the regulation of T-cell levels in SIVsm-infected sooty mangabeys |
| Q34055207 | Transmission selects for HIV-1 strains of intermediate virulence: a modelling approach |
| Q36557330 | Vaccines to prevent transmission of HIV-1 via breastmilk: scientific and logistical priorities |
| Q37086886 | Viral Evolution and Cytotoxic T Cell Restricted Selection in Acute Infant HIV-1 Infection |
| Q34216522 | Viral and host factors associated with the HIV-1 viral load setpoint in adults from Mbeya Region, Tanzania |
| Q37240053 | Viral load and CD4+ T-cell dynamics in primary HIV-1 subtype C infection. |
Search more.